Aspirin reduces the risk of colon cancer recurrence after surgery, but only in patients with a specific genetic marker ...

Short-term low-dose aspirin use prior to immunochemical fecal occult blood testing (iFOBT) significantly increased the test’s sensitivity for detecting advanced colorectal tumors, new study findings ...

The 4,000-year-old drug, most commonly used to treat pain, prevents certain tumours from forming and spreading across the ...

The test targets a potential U.S. market of over 60 million individuals and a potential global market exceeding 200 million individuals who take aspirin regularly. Physicians and laboratories ...

Low-dose aspirin may slash colorectal cancer recurrence risk by 55%, according to a recent trial. Image credit: soleg/Getty Images The National Cancer Institute predicts that colorectal cancers will ...

Dutch scientists plan to test aspirin against a rare form of cancer after genetic testing suggested the common painkiller might also kill tumor cells. The finding is the latest in a string of studies ...

A drug originally derived from willow bark thousands of years ago is sparking a medical revolution. New clinical data and ...

NEW YORK -- Aspirin, one of the world's oldest and cheapest drugs, has shown remarkable promise in treating colon cancer in people with mutations in a gene that's thought to play a role in the disease ...

“Aspirin is a drug that is readily available globally and extremely inexpensive compared to many modern cancer drugs, which ...

Despite advances in cancer treatment, many early-stage patients experience a recurrence when dormant cancer cells spread and grow into metastatic tumors. Scientists have now identified how aspirin ...

AURORA, Colo. -- A higher dose of aspirin offered no significant benefit as preeclampsia prevention in high-risk patients, although those with multifetal gestations may have seen some gains, according ...